The Recall Desk

Archive

February 2023 recalls

503 recalls were announced in February 2023.

What the numbers show

Critical
6
Severe
69
High
395
Moderate
32
Low
1

Of the 503 recalls this month scored against our rubric, 1% are Critical, 14% are Severe.

Which agencies issued them

501–503 of 503

  • ModerateFDA (Devices)·Z-1020-2023·2023-02-01

    AirQ3 Intubating Laryngeal Airway Recall: Orogastric Tube Size Labeling Discrepancy

    SunMed is recalling 43,290 AirQ3 Self Pressurizing Intubating Laryngeal Airways due to a sizing discrepancy between device labeling and actual channel dimensions. Clinicians may need to use a smaller-diameter gastric catheter than indicated.

    Product
    AirQ3 Self Pressurizing ILA with Automatic Cuff Inflation and GA Size REF Number 0.0 60005 0.5 60055 1.0 60105 1.5 60155 2.0 60205 3.0 60305 4.0 60405
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0170-2023·2023-02-01

    Metoprolol Succinate Tablets Recalled for Failed Dissolution Specification

    Ascend Laboratories is recalling 6,336 bottles of Metoprolol Succinate Extended-Release Tablets, 50 mg, distributed nationwide and in Puerto Rico, due to failed dissolution specification.

    Product
    METOPROLOL SUCCINATE — METOPROLOL SUCCINATE (METOPROLOL SUCCINATE ER TABLETS)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0176-2023·2023-02-01

    Drug Recall: S2 Racepinephrine Inhalation Solution Short Fill

    Nephron Sc Inc recalls approximately 925,920 vials of S2 Racepinephrine Inhalation Solution due to short fill. Affected lots may contain less medication than labeled.

    Product
    S2 — S2 (RACEPINEPHRINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide

Looking for a different month? Back to 2023.